DCN and metabolic dysfunction-associated steatohepatitis: Furthermore, immunofluorescence showed an increase in pSTAT3 and DCN (mainly expressed by HSCs) with a close colocation in NASH mice, which was abolished after ginkgetin treatment (Figure 6E).